Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer

Cell Death & Disease, Published online: 13 November 2021; doi:10.1038/s41419-021-04367-3Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer

Source: Cell death and disease - November 13, 2021 Category: Internal Medicine Authors: Jiawen Yang Jiajie Mo Juji Dai Chenqiao Ye Wei Cen Xuzhi Zheng Lei Jiang Lechi Ye Source Type: research